Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Ingevity Corporation

NGVT
47,87
1,63 (3,53%)
Ultimo aggiornamento: 19:51:49
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/10/202421:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:20EDGAR2Form 8-K - Current report
29/10/202421:15BWIngevity reports third quarter 2024 financial results
25/10/202422:22EDGAR2Form 8-K - Current report
16/10/202415:15BWIngevity updates third-quarter 2024 earnings release and..
03/10/202412:45EDGAR2Form 8-K - Current report
03/10/202412:15BWIngevity announces CEO transition as Fortson departs..
30/9/202415:00BWIngevity to highlight its newest Capa® polycaprolactone..
19/8/202423:26EDGAR2Form 144 - Report of proposed sale of securities
13/8/202421:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202422:26EDGAR2Form 8-K - Current report
31/7/202422:24EDGAR2Form 8-K - Current report
31/7/202422:15BWIngevity reports second quarter 2024 financial results
18/7/202415:15BWIngevity announces dates for second-quarter 2024 earnings..
17/7/202422:15BWIngevity names new general counsel and chief human resources..
09/7/202415:00BWIngevity partners with Ultrapolymers Group for European..
08/7/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202422:20EDGAR2Form 8-K - Current report
13/6/202415:00BWIngevity releases 2023 sustainability report, details..
07/5/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202422:15BWIngevity reports first quarter 2024 financial results
18/4/202422:15BWIngevity announces dates for first-quarter 2024 earnings..
11/3/202421:21EDGAR2Form ARS - Annual Report to Security Holders
11/3/202421:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/3/202421:19EDGAR2Form DEF 14A - Other definitive proxy statements
01/3/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:53EDGAR2Form 144 - Report of proposed sale of securities
26/2/202421:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202421:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202421:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202421:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:24EDGAR2Form 8-K - Current report
21/2/202422:15BWIngevity reports fourth quarter and full year 2023 financial..
08/2/202415:00BWIngevity announces dates for fourth-quarter and full year..
02/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202315:00BWIngevity extends partnership with TRiiSO, LLC, expands Capa®..
Apertura: 46,52 Min: 46,33 Max: 47,93
Chiusura: 46,24

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network